These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16276003)
1. Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshop. Zelent A; Petrie K; Lotan R; Waxman S; Gore SD Mol Cancer Ther; 2005 Nov; 4(11):1810-9. PubMed ID: 16276003 [TBL] [Abstract][Full Text] [Related]
2. Cancer epigenetics: promises and pitfalls for cancer therapy. Skourti E; Dhillon P FEBS J; 2022 Mar; 289(5):1156-1159. PubMed ID: 35233949 [TBL] [Abstract][Full Text] [Related]
3. State of the translational science: summary of Baltimore workshop on gene re-expression as a therapeutic target in cancer January 2003. Zelent A; Waxman S; Carducci M; Wright J; Zweibel J; Gore SD Clin Cancer Res; 2004 Jul; 10(14):4622-9. PubMed ID: 15269133 [TBL] [Abstract][Full Text] [Related]
8. Targeting Chromatin Remodeling for Cancer Therapy. Kaur J; Daoud A; Eblen ST Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. Bhalla KN J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549 [TBL] [Abstract][Full Text] [Related]
10. German-Catalan workshop on epigenetics and cancer. Vizoso M; Esteller M Epigenetics; 2013 Sep; 8(9):998-1003. PubMed ID: 23884202 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M; Esteller M Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706 [TBL] [Abstract][Full Text] [Related]
12. Epigenetics and MicroRNAs in Cancer. Ramassone A; Pagotto S; Veronese A; Visone R Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401683 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic changes in pediatric solid tumors: promising new targets. Lawlor ER; Thiele CJ Clin Cancer Res; 2012 May; 18(10):2768-79. PubMed ID: 22589485 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic therapy of cancer with histone deacetylase inhibitors. Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724 [TBL] [Abstract][Full Text] [Related]
16. Histone modifications and cancer. Sawan C; Herceg Z Adv Genet; 2010; 70():57-85. PubMed ID: 20920745 [TBL] [Abstract][Full Text] [Related]
17. Targeting epigenetics for cancer therapy. Park JW; Han JW Arch Pharm Res; 2019 Feb; 42(2):159-170. PubMed ID: 30806885 [TBL] [Abstract][Full Text] [Related]
18. [Epigenetics and cancer]. Xue C; Yu J; Liu H; Chen J Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1133-6. PubMed ID: 19947505 [TBL] [Abstract][Full Text] [Related]
19. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics. Duan YT; Sangani CB; Liu W; Soni KV; Yao Y Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]